Evidence map›Paper›PMID 42171687›Full record

ArticleCellular and molecular life sciences : CMLS2026

eIF5A coordinates the transcription and translation of its target genes.

Marina Barba-Aliaga, Lianqi Chi, Samoa Prieto-Díez, Jordi Planells, José García-Martínez, José E Pérez-Ortín, Paula Alepuz

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marina Barba-AliagaInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain. mbarbaaliaga@fas.harvard.edu.ORCID http://orcid.org/0000-0002-1842-9126
Lianqi ChiInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain.
Samoa Prieto-DíezInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain.
Jordi PlanellsInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain.
José García-MartínezInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain.
José E Pérez-OrtínInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain. jose.e.perez@uv.es.ORCID http://orcid.org/0000-0002-1992-513X
Paula AlepuzInstituto de Biotecnología y Biomedicina (Biotecmed), Universitat de València, Burjassot, València, 46100, Spain. paula.alepuz@uv.es.ORCID http://orcid.org/0000-0003-1472-2373

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining balanced cellular protein levels requires precise control of gene expression and effective coordination between the various stages of the process, from transcription to translation. In recent years, several components of the translation apparatus have been found in the nuclei of various eukaryotes, where they regulate transcription, mRNA processing or export, thereby integrating different stages of gene expression. eIF5A is an essential and evolutionarily conserved translation elongation factor that is involved in viral infection and in the development of diseases such as cancer and neurodevelopmental disorders. eIF5A promotes translation elongation by binding to ribosomes that stall at codons encoding problematic amino acids for peptide bond formation, such as consecutive prolines, also known as polyproline motifs. Although eIF5A shuttles between the nucleus and cytoplasm, its specific nuclear roles remain poorly defined. Here, we demonstrate that nuclear yeast eIF5A binds to chromatin and represses gene transcription by preventing the binding of RNA polymerase II. Importantly, chromatin binding and transcriptional repression by eIF5A have a higher impact on genes encoding its own translational targets. The presence of polyproline motifs in genes imposes both translation and transcriptional control by eIF5A. Furthermore, eIF5A's active engagement in cytoplasmic translation is necessary for its role in repressing transcription. Our results suggest that eIF5A coordinates gene expression by promoting the cytoplasmic translation of specific genes while repressing their transcription in the nucleus, thus ensuring efficient final protein synthesis.

Indexed as

Peptide Initiation FactorsProtein BiosynthesisRNA-Binding ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription, GeneticCell NucleusChromatinEukaryotic Translation Initiation Factor 5AProtein BindingRNA Polymerase IIChromatinEukaryotic Translation Initiation Factor 5APeptide Initiation FactorsRNA-Binding ProteinsRNA Polymerase IISaccharomyces cerevisiae ProteinseIF5AGene expressionPolyprolinesTranscription-translation crosstalkTranslation efficiencyTranslation elongation factor

Identifiers

PMID42171687
PMCPMC13376067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.